Noom Med vs. Luma Health: GLP-1 Weight Loss Compared (2026) | Luma Health
Provider Comparison · 2026

Noom Med vs. Luma Health:
Which Fits You Better?

Quick Verdict

Noom Med bundles GLP-1 medication with its behavioral-coaching app; Luma Health focuses on the medication and clinical care without an app subscription layered on top.

If you specifically want and will use Noom's behavioral coaching, that bundle has real value. If your main goal is effective, well-supported medical treatment, Luma Health's semaglutide ($197/month) and tirzepatide ($297/month) typically cost less than Noom Med's combined price.

Noom built its reputation on behavioral psychology and habit-change coaching long before entering the GLP-1 space. Noom Med extends that into medical weight loss by pairing GLP-1 prescriptions with the Noom app's daily lessons, food logging, and coaching features. That's a meaningfully different model from a medication-focused provider like Luma Health, and the right choice depends on what you actually want from a program.

Pricing: What You're Actually Paying For

Noom Med's pricing bundles two separate products: the GLP-1 medication itself, and access to the Noom app's coaching platform. Publicly reported pricing has Noom Med's combined monthly cost commonly landing somewhere in the $199-$399+ range depending on medication, dose, and plan commitment — and there's typically no option to pay for just the medication without the app subscription attached.

Luma Health's compounded semaglutide is $197/month and tirzepatide is $297/month, flat, with your medical evaluation, provider visits, dose adjustments, and shipping all included — no separate app fee. For patients who don't specifically want or use behavioral coaching software, that difference can add up to a meaningful amount over a full year of treatment. It's also worth noting that Noom Med's pricing structure means your cost can increase further if you're prescribed a higher-tier medication or dose, whereas Luma Health's flat pricing stays the same throughout your entire treatment course, from your first month through long-term maintenance.

Being Fair to Both Models

Noom's coaching platform has genuine value for patients who benefit from structured behavioral support and will actually use it consistently. The question isn't whether behavioral coaching helps — it can — it's whether you need to pay for it bundled with your medication specifically, versus choosing a free or lower-cost tracking tool alongside a medication-focused provider.

A Closer Look at What Noom's App Actually Includes

Noom's core app experience includes daily psychology-based lessons covering topics like emotional eating, food triggers, and habit formation, alongside food logging with a color-coded system that categorizes foods by density rather than strict calorie counting alone. A human coach is typically available through in-app messaging, though the level of personalization and response time can vary depending on your specific plan tier and how many other patients that coach is simultaneously supporting. Group support features connect you with other users working through similar goals, which some patients find motivating and others find unnecessary or even a bit intrusive depending on personal preference and comfort level with sharing progress publicly.

None of these features are unique to Noom specifically — similar functionality exists in free or lower-cost standalone apps — but Noom's specific combination and its years of refinement around behavior-change psychology is what patients are actually paying the premium for when they choose Noom Med over a medication-only alternative. Whether that premium is worth it comes down to a fairly simple self-assessment: have you used behavior-change apps before and stuck with them, or do you tend to try tracking tools for a few weeks before the novelty wears off? Your own history with similar tools is a better predictor of whether Noom's coaching will add value for you than any general feature comparison.

Running the Numbers on Total Annual Cost

Assume a patient on tirzepatide comparing Noom Med's bundled pricing (say $349/month at a mid-range tier) against Luma Health's flat $297/month. Over a year, that's $4,188 versus $3,564 — a $624 difference, entirely attributable to the bundled coaching layer since the medication itself doesn't differ in mechanism. For a patient who engages daily with Noom's coaching content and finds real value in it, that $624/year may be entirely justified. For a patient who downloads the app, uses it for two weeks, and then largely ignores it, that same $624 represents a real, avoidable cost for a feature that isn't being used, money that could otherwise go toward the medication itself, a gym membership, or simply staying in your pocket.

What the Clinical Evidence Actually Shows

It's worth separating the medication's effect from the coaching's effect. In the STEP 1 trial, participants in both the semaglutide group and the placebo group received the same lifestyle counseling — the roughly 14.9% average weight loss difference between groups came from the medication, not from the counseling both groups received equally. That doesn't mean behavioral support has zero value; it means the pharmacological effect is the primary driver of the outcomes typically cited in GLP-1 marketing, coaching bundle or not.

What to Know If You're Switching Between the Two

Patients moving from Noom Med to a focused provider (or vice versa) don't need to worry about the medication itself changing in any meaningful clinical way, since the active ingredient and mechanism are identical regardless of platform, provided both are prescribing the same drug at an equivalent dose. What does change is the surrounding experience: leaving Noom Med means losing access to its coaching content and habit-tracking tools, while gaining a lower total monthly cost. Moving to Noom Med from a focused provider means gaining that coaching layer at a higher price point.

If you're considering a switch, share your current dose, treatment duration, and any side effects with your new provider during intake so they can continue your treatment plan appropriately rather than restarting dose titration unnecessarily. This applies whether you're switching in either direction, and it's a step worth taking regardless of which platform you're moving to or from.

What the Evidence Actually Says About Behavioral Coaching

It's worth being precise about what behavioral coaching adds on top of GLP-1 medication, since this is often oversimplified in either direction. Structured behavioral support has shown modest additional benefit in some clinical studies when combined with medication, particularly around habit formation and adherence to lifestyle changes like protein intake and physical activity. The effect size tends to be meaningfully smaller than the medication's own effect, but it isn't zero — patients who engage consistently with structured coaching sometimes report better adherence to complementary habits, which can support (though not replace) the medication's own effect on weight.

The practical question isn't whether coaching helps in the abstract, but whether you specifically will engage with it consistently enough to see that modest additional benefit over time. Coaching content that goes unused adds cost without adding value, regardless of how well-designed the program is or how many studies support its theoretical effectiveness.

What Each Platform Actually Focuses On

Noom Med's strength is genuinely its coaching layer — daily lessons, food psychology content, and habit-tracking tools built on cognitive behavioral therapy principles, refined over many years as Noom's core product. Patients who've used and liked Noom's app before, or who want structured daily engagement beyond the medication itself, may find real value there.

Luma Health's focus is the medical side: a real evaluation from a licensed provider, ongoing dose management, and direct access to your care team for questions or side-effect concerns — without an app layer to maintain or pay for separately. If you want food-tracking functionality, a free or low-cost calorie-tracking app can cover that need without the bundled premium.

Which Fits You Better

There's no universally correct answer here — the right choice depends on whether the coaching layer is something you'll actually use, and whether you're prioritizing lowest cost or the most comprehensive built-in support structure. Patients who've had success with Noom's coaching approach in the past, or who specifically want daily structured engagement beyond medication management, tend to be the best fit for Noom Med. Patients who want efficient medical care without paying for features they won't use tend to be the best fit for a focused, flat-rate alternative.

Noom Med may be the better fit if you…
  • Already know and use the Noom app and value its coaching style
  • Want structured daily behavioral lessons alongside your medication
  • Are comfortable paying a premium for that bundled experience
Luma Health may be the better fit if you…
  • Want your medication cost to reflect just the medication and medical care
  • Prefer choosing your own tracking or coaching tools separately, if any
  • Value a flat, predictable monthly price without an app subscription

Medical care first.
No app subscription required.

Compounded semaglutide at $197/month or tirzepatide at $297/month — medical evaluation, provider visits, and shipping included.

Get Started → Or start your free health assessment

Frequently Asked Questions

Generally yes, based on publicly reported pricing. Noom Med's bundled medication-plus-app pricing commonly lands in the $199-$399+/month range, while Luma Health's flat $197/month semaglutide and $297/month tirzepatide don't include a separate app fee. Always verify current pricing directly with each provider.

Generally no — Noom Med's model bundles the GLP-1 prescription with app access, without a medication-only option. If you specifically want the medication without the coaching layer, a standalone provider is typically the more cost-effective path.

Clinical trial data shows the medication itself is the primary driver of the weight-loss results typically cited (both treatment and placebo groups in trials received the same lifestyle counseling). Behavioral coaching may still provide value for individual habit change, but it isn't what accounts for the headline efficacy numbers.

Noom does offer standalone coaching app subscriptions separate from its GLP-1 medication program in some cases. This can let you pair Noom's coaching tools with a different medication provider if you want both without paying the full bundled premium — confirm current standalone availability directly with Noom.

No. Both prescribe the same active ingredients (semaglutide or tirzepatide), whether compounded or brand-name. The clinical mechanism and expected outcomes are the same regardless of which platform prescribes it; what differs is pricing structure, coaching inclusion, and support model.

Your medical evaluation, ongoing provider visits, dose adjustments, and free shipping are all included in the flat $197/month semaglutide or $297/month tirzepatide price — no separate app, coaching, or consultation fees.

Not necessarily, if you share your current dose and treatment history with your new provider. This allows them to continue your treatment at an appropriate level rather than restarting titration unnecessarily.

Some studies suggest a modest additional benefit for adherence and habit formation, though the effect is meaningfully smaller than the medication's own effect. The benefit depends heavily on whether a patient consistently engages with the coaching content.

Yes. You can start with a focused, flat-rate provider and add a separate coaching app or tool later if you find you want that additional structure, without needing to switch your medication provider.

References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567185
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PubMed 35658024
  3. U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov. 2025. FDA Drug Approvals Database
  4. U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov
Medical Disclaimer: This article is for educational purposes and is not a substitute for professional medical advice. Individual results and needs vary; consult a licensed healthcare provider before starting, stopping, or changing any treatment or supplement. This article reflects information available as of July 2026. Luma Health's compounded medications are not themselves FDA-approved as finished drug products; their active ingredients are FDA-approved in commercial formulations such as Ozempic, Wegovy, Mounjaro, and Zepbound.